Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs.
Related Posts
Insiders at UnitedHealth are scooping up tarnished shares
Kristen Gil, a director at the firm, bought 3,700 shares worth roughly $1 million on Thursday.
S&P 500 hits record to start the week, traders look to key earnings: Live updates
- andrewkewnzy@gmail.com
- October 14, 2024
- 0
The early signs of recovery in the banking sector helped push the broader market to all-time highs at the end of last week.
Japan Prime Minister Ishiba considers Trump trade meeting ahead of June G-7 summit, says Yomiuri newspaper
Japan, a major U.S. ally, faces a 24% tariff from next month unless it can negotiate a bilateral deal.